Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Arber

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2025
Enrichment of CD7<sup>+</sup>CXCR3<sup>+</sup> CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphomaR Bartolini, L Trueb, D Daoudlarian, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Bone Marrow Transplantation|June 30, 2009
Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignanciesG Stussi, J Halter, A Tichelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2025
Enrichment of CD7<sup>+</sup>CXCR3<sup>+</sup> CAR T-cells in infusion products is associated with durable remission in relapsed or refractory diffuse large B-cell lymphomaR Bartolini, L Trueb, D Daoudlarian, et al.
Bone Marrow Transplantation|March 8, 2007
High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantationA S Buser, M Stern, C Bucher, et al.
Pageof 2